"Window of Opportunity" in Ocular Graft-Versus-Host Disease Treatment: Results of a Longitudinal Study and Case Reports.

IF 2 4区 医学 Q2 OPHTHALMOLOGY Eye & Contact Lens-Science and Clinical Practice Pub Date : 2024-05-01 Epub Date: 2024-03-13 DOI:10.1097/ICL.0000000000001081
Bayasgalan Surenkhuu, Christine S Mun, Christian Kim, Nour Yanna Atassi, Jessica Mun, Nikhil Dhall, Sarah Abdel-Hadi, Tanya Sheth, Priyanka Dondeti, Alexandria Bernal, Anubhav Pradeep, Damiano Rondelli, Sandeep Jain
{"title":"\"Window of Opportunity\" in Ocular Graft-Versus-Host Disease Treatment: Results of a Longitudinal Study and Case Reports.","authors":"Bayasgalan Surenkhuu, Christine S Mun, Christian Kim, Nour Yanna Atassi, Jessica Mun, Nikhil Dhall, Sarah Abdel-Hadi, Tanya Sheth, Priyanka Dondeti, Alexandria Bernal, Anubhav Pradeep, Damiano Rondelli, Sandeep Jain","doi":"10.1097/ICL.0000000000001081","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To perform a longitudinal study for determining the development of ocular graft-versus-host disease (oGVHD) after allogeneic hematopoietic stem cell transplant (HSCT) and report cases that illustrate the \"window of opportunity\" concept in oGVHD treatment.</p><p><strong>Methods: </strong>Patients (n=61) were examined at prescheduled clinic visits before HSCT and three-month intervals after HSCT for 2 years. The presence or absence of oGVHD was determined using the international chronic oGVHD consensus group diagnostic criteria. Ocular surface washings (OSW) were obtained at each visit and analyzed for cytokine levels.</p><p><strong>Results: </strong>In the longitudinal study, 26.2% (n=16; progressed group) developed either probable (11.5%, n=7) or definite oGVHD (14.8%, n=9). In the progressed group, clinically significant changes in signs (corneal staining and Schirmer I test) and symptoms at the post-HSCT visit as compared with the pre-HSCT visit occurred at 9 months. Significant differences in clinical signs and symptoms (whether average post-HSCT values or changes in values over pre-HSCT levels) between the progressed and nonprogressed groups occurred at a 9-month visit or later. In the progressed group, 55.6% of eyes that had negative matrix metalloproteinase 9 (MMP-9) test at pre-HSCT turned MMP-9 positive at 3 to 6 months post-HSCT. In the progressed group, interleukin 8 levels in OSW were significantly increased at 6 months post-HSCT. In the case reports, the \"window of opportunity\" was detected by MMP-9 turning positive, early corneal staining, interleukin 8 increase in OSW, and peripheral corneal epithelial thinning, which resolved with treatment initiation.</p><p><strong>Conclusions: </strong>A \"window of opportunity\" exists before patients developing symptomatic tear-deficient dry eye after HSCT for initiating treatment that may preempt oGVHD development; however, larger-scale longitudinal studies are needed for definitive recommendations.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"222-232"},"PeriodicalIF":2.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037456/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye & Contact Lens-Science and Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICL.0000000000001081","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To perform a longitudinal study for determining the development of ocular graft-versus-host disease (oGVHD) after allogeneic hematopoietic stem cell transplant (HSCT) and report cases that illustrate the "window of opportunity" concept in oGVHD treatment.

Methods: Patients (n=61) were examined at prescheduled clinic visits before HSCT and three-month intervals after HSCT for 2 years. The presence or absence of oGVHD was determined using the international chronic oGVHD consensus group diagnostic criteria. Ocular surface washings (OSW) were obtained at each visit and analyzed for cytokine levels.

Results: In the longitudinal study, 26.2% (n=16; progressed group) developed either probable (11.5%, n=7) or definite oGVHD (14.8%, n=9). In the progressed group, clinically significant changes in signs (corneal staining and Schirmer I test) and symptoms at the post-HSCT visit as compared with the pre-HSCT visit occurred at 9 months. Significant differences in clinical signs and symptoms (whether average post-HSCT values or changes in values over pre-HSCT levels) between the progressed and nonprogressed groups occurred at a 9-month visit or later. In the progressed group, 55.6% of eyes that had negative matrix metalloproteinase 9 (MMP-9) test at pre-HSCT turned MMP-9 positive at 3 to 6 months post-HSCT. In the progressed group, interleukin 8 levels in OSW were significantly increased at 6 months post-HSCT. In the case reports, the "window of opportunity" was detected by MMP-9 turning positive, early corneal staining, interleukin 8 increase in OSW, and peripheral corneal epithelial thinning, which resolved with treatment initiation.

Conclusions: A "window of opportunity" exists before patients developing symptomatic tear-deficient dry eye after HSCT for initiating treatment that may preempt oGVHD development; however, larger-scale longitudinal studies are needed for definitive recommendations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
眼部移植物抗宿主病治疗的 "机会之窗":纵向研究结果和病例报告。
研究目的进行一项纵向研究,以确定异基因造血干细胞移植(HSCT)后眼移植物抗宿主疾病(oGVHD)的发展情况,并报告说明oGVHD治疗中 "机会之窗 "概念的病例:方法:在造血干细胞移植前和造血干细胞移植后的两个月内,患者(n=61)在预先安排的门诊就诊时接受检查。采用国际慢性眼恶性肿瘤共识小组的诊断标准确定是否存在眼恶性肿瘤。每次就诊均采集眼表冲洗液(OSW)并分析细胞因子水平:在纵向研究中,26.2%的患者(16 例;进展组)出现了可能的(11.5%,7 例)或明确的眼球血管疾病(14.8%,9 例)。在进展组中,HSCT 后就诊时的体征(角膜染色和 Schirmer I 试验)和症状与 HSCT 前就诊时相比,在 9 个月时发生了显著的临床变化。进展组和非进展组的临床症状和体征(无论是 HSCT 后的平均值还是与 HSCT 前水平相比的变化值)在 9 个月或之后的就诊中出现了显著差异。在进展组中,55.6% 的眼睛在接受造血干细胞移植前基质金属蛋白酶 9(MMP-9)检测呈阴性,但在接受造血干细胞移植后 3 至 6 个月时,MMP-9 转为阳性。在进展组中,OSW 中的白细胞介素 8 水平在 HSCT 术后 6 个月明显升高。在病例报告中,MMP-9转为阳性、早期角膜染色、OSW中白细胞介素8升高以及周边角膜上皮变薄都是 "机会之窗 "的检测指标,这些指标在开始治疗后都得到了改善:造血干细胞移植后出现无症状泪液缺乏性干眼症的患者在开始治疗前存在 "机会之窗",可避免发生oGVHD;然而,需要进行更大规模的纵向研究才能提出明确建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.50
自引率
4.30%
发文量
150
审稿时长
6-12 weeks
期刊介绍: Eye & Contact Lens: Science and Clinical Practice is the official journal of the Contact Lens Association of Ophthalmologists (CLAO), an international educational association for anterior segment research and clinical practice of interest to ophthalmologists, optometrists, and other vision care providers and researchers. Focusing especially on contact lenses, it also covers dry eye disease, MGD, infections, toxicity of drops and contact lens care solutions, topography, cornea surgery and post-operative care, optics, refractive surgery and corneal stability (eg, UV cross-linking). Peer-reviewed and published six times annually, it is a highly respected scientific journal in its field.
期刊最新文献
Contact Lens Regulation: Where Have We Been, Where are We Going? Corneal Refractive Surgery Considerations in Patients With History of Orthokeratology. Evaluation of Cyanoacrylate Tissue Adhesive Glue Application Outcomes in Corneal Thinning and Perforation. Spotlight on Amniotic Membrane Extract Eye Drops: A Review of the Literature. Corneal Clarity and Tomographic Patterns in Pseudoexfoliation Syndrome: A Severity-Based Investigation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1